Brain-age changes after exercise tracked symptoms in schizophrenia-spectrum disorders
An analysis of trial data linked changes in a brain-age biomarker with cognition and negative symptoms; it did not report a controlled exercise effect.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Among people with schizophrenia spectrum disorders, higher starting body mass index was associated with a larger reduction in a brain-age biomarker after exercise. Biomarker changes also tracked improvements in negative symptoms and cognition. These linked changes do not establish that exercise reversed brain aging or that body weight determined who would benefit.
This abstract-based account includes fewer post-exercise observations than baseline observations, without explaining the difference. It reports no comparison-group effect estimate, so causal claims about exercise or body mass index remain unsupported.
What the brain measure represents
Researchers treated the brain age gap as an indicator of brain health and potential recovery. It is a biomarker, so a change in this measure should be distinguished from a demonstrated clinical treatment benefit.
How the changes were connected
The analysis connected changes in the biomarker with symptom and cognitive changes. This is useful for asking whether the marker tracks clinical status, but it does not establish that the marker itself explains improvement.
The original publication
Brain age gap reduction following exercise mirrors clinical improvements in schizophrenia spectrum disorders.
Yilmaz D, Papiol S, Keeser D et al.
Neuroimage Clin · 2025
- PubMed ID
- 41067091
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.